发明名称 |
Method of using vasoconstrictive agents during energy-based tissue therapy |
摘要 |
A mammal undergoing an energy-based therapy is treated by administering at least one vasoconstrictive agent to the mammal prior to or during the procedure. The at least one vasoconstrictive agent is added in amounts sufficient to reduce or prevent vasodilation. This treatment method increases or promotes the size of the coagulation zone created after energy-based therapy. |
申请公布号 |
US8968234(B2) |
申请公布日期 |
2015.03.03 |
申请号 |
US201213486058 |
申请日期 |
2012.06.01 |
申请人 |
Covidien AG |
发明人 |
Podhajsky Ronald J. |
分类号 |
A61B18/00;A61B18/18;A61K31/00;A61K31/522 |
主分类号 |
A61B18/00 |
代理机构 |
|
代理人 |
|
主权项 |
1. A surgical technique comprising:
administering at least one adenosine receptor antagonist selected from the group consisting of 8SPT, MRS1754, MRS1220, MRE3008F20, MRS1523, and ATL146e to a patient; and performing an energy-based therapy to form a coagulation zone. |
地址 |
CH |